본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Proteogenix

[Proteogenix] Dezamizumab Biosimilar – Anti-APCS mAb – Research Grade

Cat-No. PX-TA1441


Proteogenix는 Primary Antibody Biosimilar - Research Grade 

제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.




제품 설명 


Dezamizumab Biosimilar – Anti-APCS mAb – Research Grade

  



제품 번호

 

PX-TA1441

 



제품 특징


Product nameDezamizumab Biosimilar - Anti-APCS mAb - Research Grade
SourceCAS 1662664-56-3
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsDezamizumab,GSK-2398852,APCS,anti-APCS
ReferencePX-TA1441
NoteFor research use only. Not suitable for human use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody


Description of Dezamizumab Biosimilar - Anti-APCS mAb - Research Grade

General information on Anti-APCS[Homo sapiens] (Dezamizumab) Monoclonal Antibody

Dezamizumab has been investigated for the treatment of AL amyloidosis.




QC & Validation Data


SDS-PAGE for Dezamizumab Biosimilar - Anti-APCS mAb

Dezamizumab Biosimilar - Anti-APCS mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.




Publications


  • Doran, E; (2024) The role of human pentraxins for the Leishmania-vector interaction. PhD thesis, London School of Hygiene & Tropical Medicine. DOI: https://doi.org/10.17037/PUBS.04672257




ProteoGenix의 모든 제품들을 만나보세요!

 

Proteogenix - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"